| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |